Original Research | ||||||||||||||||||||||||||||||
RMJ. 2019; 44(2): 302-307 Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia Bong Ju Lee.
|
How to Cite this Article |
Pubmed Style Bong Ju Lee. Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. RMJ. 2019; 44(2): 302-307. Web Style Bong Ju Lee. Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. https://www.rmj.org.pk/?mno=26572 [Access: December 05, 2023]. AMA (American Medical Association) Style Bong Ju Lee. Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. RMJ. 2019; 44(2): 302-307. Vancouver/ICMJE Style Bong Ju Lee. Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. RMJ. (2019), [cited December 05, 2023]; 44(2): 302-307. Harvard Style Bong Ju Lee (2019) Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. RMJ, 44 (2), 302-307. Turabian Style Bong Ju Lee. 2019. Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. Rawal Medical Journal, 44 (2), 302-307. Chicago Style Bong Ju Lee. "Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia." Rawal Medical Journal 44 (2019), 302-307. MLA (The Modern Language Association) Style Bong Ju Lee. "Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia." Rawal Medical Journal 44.2 (2019), 302-307. Print. APA (American Psychological Association) Style Bong Ju Lee (2019) Efficacy of paliperidone palmitate on psychiatric symptoms and attitudes toward medication in schizophrenia. Rawal Medical Journal, 44 (2), 302-307. |